Eugia's facility in India was recently slammed with a Form 483 listing 7 manufacturing observations. That wrist-slap was preceded in January by the unit’s facility in NJ receiving a Form 483 from a December inspection. Welcome to "American" medicine. tinyurl.com/38z427zf

More of this, please. The new NC plant will create high-performance, pre-fillable polymer & glass syringes, which help in the delivery & storage of medicines like mRNA vaccines. Your medicines & delivery devices should be made in America. #PILLSAct tinyurl.com/2u5zanpp

More evidence supports the urgent need for Congress to quickly take up & pass Rep. Claudia Tenney's #PILLSAct: CPA Chief Economist Jeff Ferry details a surge in pharmaceutical imports that's threatening U.S. national security as India/China dominance grows ⬇ tinyurl.com/z8jf6zyz

The fallout of grievous quality issues in India – the world’s 3rd largest pharmacy & largest exporter of generics to the U.S. – is sweeping. The crisis has compelled Washington to turn to China, despite broader efforts to reduce reliance on the nation. 🔗 tinyurl.com/mtjruzvd

🚨 ALERT: The U.S. FDA said that last week, it sent warning letters to three Chinese manufacturers as well as two firms marketing and distributing unauthorized plastic syringes made in China that are not cleared by the FDA for use in the U.S. MORE ➔ tinyurl.com/4u4v7tk4

America’s dangerous drug shortage crisis stems from an excessive dependence on imported pharmaceuticals, especially those produced in China and India. And it's getting worse. NEW Op-Ed from CPA Chief Economist @MenloFerry ⬇ tinyurl.com/ypvsdvjt

We can only hope this high-water mark energizes efforts in Congress & federal agencies to address the broken market around what are often critical generic drugs. America's medicine should be safe, affordable, & ALWAYS available. tinyurl.com/249pvfkn

U.S. dependence on imports for drugs & basic medical devices is dangerous, & U.S. FDA knows it. Complaints about faulty syringes made in China date back to 2020. The Veterans Affairs has taken action, recently banning the use of the dangerous syringes. tinyurl.com/3rnzty59

With legislative efforts picking up to combat a record-high number of U.S. shortages, a new report from U.S. Pharmacopeia (USP) pinpoints low prices, manufacturing complexity, geographic concentration of production, & quality issues as key contributors. tinyurl.com/4t9r5433

When the U.S. FDA comes knocking at your drug manufacturing facility, it’s best to play along. Unfortunately for Jiangsu Hengrui Pharmaceuticals, the company’s refusal to do so has resulted in a scathing production write-up from the U.S. regulator. tinyurl.com/2jew8hsb

Foreign government subsidies and U.S. FDA regulatory failures are causing the drug shortage crisis in the United States—and making it worse. In the first three months of 2024, there were 323 active drug shortages, the highest number since 2001. 🔗 tinyurl.com/y8rveadb

CVS, which outsources production to foreign companies for its store-brand drugs is “responsible for the drugs made by the contract facility,” per U.S. FDA. That's created a concerning gap in oversight of everyday medicines Americans take to save money. 🔗 tinyurl.com/5y2yn4jr

America has become dangerously dependent on foreign manufacturers—particularly in China & India—for generic drugs. CPA's @NickIacovella examines how to secure U.S. drug supply chains & ensure patients have access to safe, quality, reliable medication. 🔗 tinyurl.com/3m8c2r7n

America has become dangerously reliant on foreign manufacturers — particularly in China & India — for the generic drugs that account for 91% of U.S. prescriptions dispensed. Without immediate action from Congress, the forecast could be life-threatening. tinyurl.com/48hnuuxx

As of June, the U.S. has 232 drugs in short supply; some of them critical, some basic medications. Nearly all of them are imported generics. The U.S. has long outsourced its generic drug-making manufacturing overseas, & the consequences can't be ignored. tinyurl.com/2udjebzc

NEW: Republican vice presidential nominee Sen. @JDVance1 (R-OH) sounded the alarm on China making most of the pharmaceuticals used in the United States during a speech in his hometown of Middletown, Ohio, yesterday. From John ➔ tinyurl.com/bdhej7dx

NEW: U.S. FDA hits Aurobindo's Eugia with “Official Action Indicated” designation in the wake of a failed plant inspection in India, citing 7 observations related to the failure of employees to follow procedures intended to prevent microbial contamination. tinyurl.com/bdhrkpn3

New U.S. FDA Warning Letter to Aurobindo's Eugia Pharma underscores a disturbing pattern of malfeasance by the Indian drugmaker. Aurobindo's violations of good manufacturing practices make America's medicine less safe & put patients at considerable risk. tinyurl.com/48e9d6b

84% of voters support the U.S. FDA using import bans on foreign labs like Zydus that are issued Warning Letters (multiple, in this case) for failing inspections. The FDA's job is ensuring American patients have access to safe, high-quality medicine. tinyurl.com/3wu8wfn6

We agree, JD Vance. Read more about America's dangerous dependence on foreign manufacturers — particularly in China and India — for generic drugs that account for 91% of all U.S. prescriptions. tinyurl.com/4a47h7d8